These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 21608081)
1. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Deleidi M; Hargus G; Hallett P; Osborn T; Isacson O Stem Cells; 2011 Jul; 29(7):1052-63. PubMed ID: 21608081 [TBL] [Abstract][Full Text] [Related]
2. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606 [TBL] [Abstract][Full Text] [Related]
3. Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum. Fink KD; Rossignol J; Lu M; Lévêque X; Hulse TD; Crane AT; Nerriere-Daguin V; Wyse RD; Starski PA; Schloop MT; Dues DJ; Witte SJ; Song C; Vallier L; Nguyen TH; Naveilhan P; Anegon I; Lescaudron L; Dunbar GL Cell Transplant; 2014; 23(11):1407-23. PubMed ID: 23879897 [TBL] [Abstract][Full Text] [Related]
4. MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy Model. Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Eiraku S; Harada A; Matsunaga K; Watabe T; Toda K; Hatazawa J; Sawa Y Transplantation; 2019 Aug; 103(8):1582-1590. PubMed ID: 31107828 [TBL] [Abstract][Full Text] [Related]
5. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease. Doi D; Magotani H; Kikuchi T; Ikeda M; Hiramatsu S; Yoshida K; Amano N; Nomura M; Umekage M; Morizane A; Takahashi J Nat Commun; 2020 Jul; 11(1):3369. PubMed ID: 32632153 [TBL] [Abstract][Full Text] [Related]
6. No Tumorigenicity of Allogeneic Induced Pluripotent Stem Cells in Major Histocompatibility Complex-matched Cynomolgus Macaques. Ishigaki H; Pham VL; Terai J; Sasamura T; Nguyen CT; Ishida H; Okahara J; Kaneko S; Shiina T; Nakayama M; Itoh Y; Ogasawara K Cell Transplant; 2021; 30():963689721992066. PubMed ID: 33588604 [TBL] [Abstract][Full Text] [Related]
8. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. Kikuchi T; Morizane A; Doi D; Onoe H; Hayashi T; Kawasaki T; Saiki H; Miyamoto S; Takahashi J J Parkinsons Dis; 2011; 1(4):395-412. PubMed ID: 23933658 [TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology. Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041 [TBL] [Abstract][Full Text] [Related]
10. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege. Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313 [TBL] [Abstract][Full Text] [Related]
11. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains. Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934 [TBL] [Abstract][Full Text] [Related]
12. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Kawamura T; Miyagawa S; Fukushima S; Maeda A; Kashiyama N; Kawamura A; Miki K; Okita K; Yoshida Y; Shiina T; Ogasawara K; Miyagawa S; Toda K; Okuyama H; Sawa Y Stem Cell Reports; 2016 Mar; 6(3):312-20. PubMed ID: 26905198 [TBL] [Abstract][Full Text] [Related]
13. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling. Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671 [TBL] [Abstract][Full Text] [Related]
14. Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons. Peng SP; Schachner M; Boddeke E; Copray S Cell Reprogram; 2016 Apr; 18(2):55-66. PubMed ID: 26990843 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and banking of clinical-grade cells for neural transplantation: Scale up, fingerprinting, and genomic stability of stem cell lines. Natalwala A; Kunath T Prog Brain Res; 2017; 230():133-150. PubMed ID: 28552226 [TBL] [Abstract][Full Text] [Related]
16. NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats. Yu SJ; Wang YC; Chang CY; Hsieh W; Chen S; Yang CS; Lin SZ; Wang Y Brain Res; 2019 Sep; 1719():124-132. PubMed ID: 31153914 [TBL] [Abstract][Full Text] [Related]
17. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease. Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963 [TBL] [Abstract][Full Text] [Related]
18. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788 [TBL] [Abstract][Full Text] [Related]
19. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease. Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741 [TBL] [Abstract][Full Text] [Related]